Sunday, July 13, 2014 12:12:38 AM
http://www.forbes.com/sites/matthewherper/2014/01/27/how-to-avert-antibiotic-apocalypse/
Full disclosure: I am long Cellceutix (CTIX), a very small cap company-under $200 Million and stock price under $2.00. They have a very promising antibiotic, brilacidin, in human trials now, set to report results in a couple of months. Here’s a recent press release that explains it better than I can. CTIX also has a cancer drug in trials at Harvard’s Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Center. https://finance.yahoo.com/news/cellceutix-brilacidin-absssi-trial-gets-110000777.html
This is such a small company that its under the radar and so has the potential to be a life changing investment. The several drugs in their pipeline have the potential to save lives. I’d be happy to read your comments on CTIX.
Thanks for your interesting article.
George Harvey
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM